Recently, several mechanisms have been proposed for the development of castration-resistant prostate cancer(3,4)including mutation, amplification(4,5), expression alternative-splice variants of the androgen receptor(6), or the increase of natural testosterone biosynthesis by cancer cells. This evidence concerns the gene AR and prostate cancer.